|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
5820 Oberlin Drive, Suite 101, San Diego, California 92121, US
|
|
Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.
|
Belite Bio Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Belite Bio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Belite Bio customer service number in your country click here to find.
Tom Lin is the CEO of Belite Bio. To contact Tom Lin email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.